Moxifloxacin and Encephalopathy - a phase IV clinical study of FDA data

Summary:

Encephalopathy is reported as a side effect among people who take Moxifloxacin (moxifloxacin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Mycobacterial infection.

The phase IV clinical study analyzes which people have Encephalopathy when taking Moxifloxacin. It is created by eHealthMe based on reports of 12,960 people who have side effects when taking Moxifloxacin from the FDA, and is updated regularly.

What is Moxifloxacin?

Moxifloxacin has active ingredients of moxifloxacin. eHealthMe is studying from 12,980 Moxifloxacin users. Check the latest studies of Moxifloxacin.

What is Encephalopathy?

Encephalopathy (functioning of the brain is affected by some agent or condition) is found to be associated with 1,466 drugs and 1,602 conditions by eHealthMe. Check the latest studies of Encephalopathy.

On Jul, 09, 2026

12,960 people reported to have side effects when taking Moxifloxacin.
Among them, 28 people (0.22%) have Encephalopathy.

Could Moxifloxacin cause Encephalopathy?

Among these 28 people:

How long have people been on Moxifloxacin when they have Encephalopathy? *

What is the gender of people who have Encephalopathy when taking Moxifloxacin? *

female: 14.81 %
male: 85.19 %

What is the age of people who have Encephalopathy when taking Moxifloxacin? *

What are other drugs people take besides Moxifloxacin? *

What are other side effects people have besides Encephalopathy? *

Acute Kidney Failure: 6 people, 21.43%
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 5 people, 17.86%
Septic Shock (shock due to blood infection): 5 people, 17.86%
Pneumonia: 4 people, 14.29%
Fall: 4 people, 14.29%
Consciousness - Decreased: 4 people, 14.29%
Weakness: 3 people, 10.71%
Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 3 people, 10.71%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 10.71%
Depressed Level Of Consciousness: 3 people, 10.71%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 14.29%
Mycobacterial Infection: 4 people, 14.29%
Bladder Cancer: 3 people, 10.71%
Stress And Anxiety: 3 people, 10.71%
Agitation (state of anxiety or nervous excitement): 2 people, 7.14%
Depression: 2 people, 7.14%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 2 people, 7.14%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.14%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 7.14%
Confusional State: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Moxifloxacin and have Encephalopathy?

- Check whether Encephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Moxifloxacin:

Moxifloxacin (12,980 reports)

Encephalopathy treatments and more:

Encephalopathy (27,832 reports)

Browse all side effects of Moxifloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalopathy:

Encephalopathy (1,466 drugs)

Browse all the conditions that are associated with Encephalopathy:

Encephalopathy (1,602 conditions)

Related publications that referenced our studies

Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .
Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on moxifloxacin (the active ingredients of Moxifloxacin) and Moxifloxacin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.